M. Finet

553 total citations
32 papers, 438 citations indexed

About

M. Finet is a scholar working on Molecular Biology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, M. Finet has authored 32 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Surgery and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in M. Finet's work include Ion channel regulation and function (6 papers), Nitric Oxide and Endothelin Effects (5 papers) and Cardiac electrophysiology and arrhythmias (5 papers). M. Finet is often cited by papers focused on Ion channel regulation and function (6 papers), Nitric Oxide and Endothelin Effects (5 papers) and Cardiac electrophysiology and arrhythmias (5 papers). M. Finet collaborates with scholars based in France, Belgium and United Kingdom. M. Finet's co-authors include Théophile Godfraind, T Godfraind, Gilberto De Nucci, John R. Vane, Karine Cohen-Solal, François Noël, Edwin Milgröm, M. Perrot-Applanat, George H. Khoury and Rémy Hanf and has published in prestigious journals such as Circulation, The Journal of Physiology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

M. Finet

32 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Finet France 12 171 153 137 110 72 32 438
Jocelyne Condo France 12 127 0.7× 274 1.8× 36 0.3× 121 1.1× 70 1.0× 19 537
Stuart Kupfer United States 9 248 1.5× 65 0.4× 102 0.7× 51 0.5× 26 0.4× 13 583
Yingjie Chu China 12 250 1.5× 175 1.1× 45 0.3× 60 0.5× 10 0.1× 37 563
Maria Giovanna Valente Italy 12 82 0.5× 29 0.2× 86 0.6× 19 0.2× 43 0.6× 22 368
Michael G. Rolf United Kingdom 7 110 0.6× 176 1.2× 38 0.3× 23 0.2× 15 0.2× 13 439
Takahisa Deguchi Japan 10 89 0.5× 48 0.3× 77 0.6× 30 0.3× 4 0.1× 25 295
Michèle Heimburger France 10 261 1.5× 436 2.8× 42 0.3× 37 0.3× 11 0.2× 23 646
Bastianina Zanda Italy 8 155 0.9× 184 1.2× 42 0.3× 21 0.2× 9 0.1× 10 435
Silke Becker United Kingdom 8 122 0.7× 77 0.5× 146 1.1× 28 0.3× 5 0.1× 13 345
Shizu Aikawa Japan 13 228 1.3× 18 0.1× 53 0.4× 52 0.5× 30 0.4× 38 629

Countries citing papers authored by M. Finet

Since Specialization
Citations

This map shows the geographic impact of M. Finet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Finet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Finet more than expected).

Fields of papers citing papers by M. Finet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Finet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Finet. The network helps show where M. Finet may publish in the future.

Co-authorship network of co-authors of M. Finet

This figure shows the co-authorship network connecting the top 25 collaborators of M. Finet. A scholar is included among the top collaborators of M. Finet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Finet. M. Finet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tímári, Géza, et al.. (2012). Evaluation of SSR161421, a novel orally active adenosine A3 receptor antagonist on pharmacology models. European Journal of Pharmacology. 699(1-3). 172–179. 6 indexed citations
2.
Tímári, Géza, et al.. (2012). Interaction of SSR161421, a novel specific adenosine A3 receptor antagonist with adenosine A3 receptor agonists both in vitro and in vivo. European Journal of Pharmacology. 699(1-3). 62–66. 2 indexed citations
3.
Renaud, Justine, et al.. (2001). Cyclo‐oxygenase and lipoxygenase pathways in mast cell dependent‐neurogenic inflammation induced by electrical stimulation of the rat saphenous nerve. British Journal of Pharmacology. 132(7). 1581–1589. 32 indexed citations
4.
Carpentier, P., et al.. (1999). Respective role of lipoxygenase and nitric oxide‐synthase pathways in plasma histamine‐induced macromolecular leakage inconscious hamsters. British Journal of Pharmacology. 126(8). 1801–1809. 3 indexed citations
5.
Delaforge, M., et al.. (1999). The cyclo‐oxygenase‐dependent regulation of rabbit vein contraction: evidence for a prostaglandin E2‐mediated relaxation. British Journal of Pharmacology. 126(1). 35–44. 5 indexed citations
6.
7.
Carpentier, P., et al.. (1998). Histamine‐induced biphasic macromolecular leakage in the microcirculation of the conscious hamster: evidence for a delayed nitric oxide‐dependent leakage. British Journal of Pharmacology. 123(5). 943–951. 11 indexed citations
8.
Carpentier, P., et al.. (1998). l-Arginine and NG-nitro-l-arginine methyl ester cause macromolecule extravasation in the microcirculation of awake hamsters. European Journal of Pharmacology. 346(2-3). 275–282. 12 indexed citations
9.
Kockx, Mark, et al.. (1998). Vascular Remodeling in Varicose Veins. Angiology. 49(11). 871–877. 58 indexed citations
10.
Finet, M., et al.. (1997). Roles of NO-Synthase and Cyclooxygenase in Sex- and Pregnancy-Dependent Arterial and Venous Pressures in the Rat. Journal of Cardiovascular Pharmacology. 30(2). 205–213. 4 indexed citations
11.
Finet, M., et al.. (1997). Comparison of the nitric oxide and cyclo‐oxygenase pathway in mesenteric resistance vessels of normotensive and spontaneously hypertensive rats. British Journal of Pharmacology. 121(3). 588–594. 8 indexed citations
12.
Perrot-Applanat, M., Karine Cohen-Solal, Edwin Milgröm, & M. Finet. (1995). Progesterone Receptor Expression in Human Saphenous Veins. Circulation. 92(10). 2975–2983. 51 indexed citations
13.
Schleiffer, R., et al.. (1991). EFFECT OF PARATHYROIDECTOMY ON DEVELOPMENT OF HYPERTENSION AND ATRIAL RESPONSIVENESS IN SPONTANEOUS HYPERTENSIVE RATS. Clinical and Experimental Pharmacology and Physiology. 18(3). 145–154. 1 indexed citations
14.
Finet, M., Guadalupe Bravo, & Théophile Godfraind. (1989). The protective action of R56865 against ouabain-induced intoxication in rat heart isolated atria and ventricles. European Journal of Pharmacology. 164(3). 555–563. 11 indexed citations
15.
Godfraind, Théophile, Cécile Eglème, M. Finet, & P. Jaumin. (1987). The Actions of Nifedipine and Nisoldipine on the Contractile Activity of Human Coronary Arteries and Human Cardiac Tissuein Vitro. Pharmacology & Toxicology. 61(2). 79–84. 36 indexed citations
16.
Finet, M. & Théophile Godfraind. (1986). Selective inhibition by ethylisopropylamiloride of the positive inotropic effect evoked by low concentrations of ouabain in rat isolated ventricles. British Journal of Pharmacology. 89(3). 533–538. 8 indexed citations
17.
Finet, M., Théophile Godfraind, & George H. Khoury. (1984). The Inotropic Action of Bay K-8644 in Rat Isolated Atria and Ventricles. DIAL (Catholic University of Leuven). 268(1). 167–167. 4 indexed citations
18.
Godfraind, T, et al.. (1984). Contractile activity of human coronary arteries and human myocardium in vitro and their sensitivity to calcium entry blockade by nifedipine.. Journal of Pharmacology and Experimental Therapeutics. 230(2). 514–518. 28 indexed citations
19.
Finet, M., François Noël, & Théophile Godfraind. (1983). Dihydroouabain Antagonism of Ouabain Action in Rat-heart. Digital Access to Libraries. 264(2). 326–326. 1 indexed citations
20.
Finet, M., et al.. (1983). The inotropic effect of ouabain and its antagonism by dihydroouabain in rat isolated atria and ventricles in relation to specific binding sites. British Journal of Pharmacology. 80(4). 751–759. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jocelyne Condo Breakdown of academic impact, for papers by Stuart Kupfer Breakdown of academic impact, for papers by Yingjie Chu Breakdown of academic impact, for papers by Maria Giovanna Valente Breakdown of academic impact, for papers by Michael G. Rolf Breakdown of academic impact, for papers by Takahisa Deguchi Breakdown of academic impact, for papers by Michèle Heimburger Breakdown of academic impact, for papers by Bastianina Zanda Breakdown of academic impact, for papers by Silke Becker Breakdown of academic impact, for papers by Shizu Aikawa
Rankless by CCL
2026